| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 7e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |